SCHEMBL24377040

SCHEMBL24377040

c1ccc(-c2ccc(-c3ccc4cc(-c5nc(-c6ccc7ccccc7c6)nc(-c6ccc7ccccc7c6)n5)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ADORA2A P29274 2/20 0.46
ADORA1 P30542 2/20 0.46
CYP1A1 P04798 1/20 0.45
CYP1B1 Q16678 1/20 0.45
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
CYP17A1 P05093 1/20 0.43
CYP19A1 P11511 1/20 0.43
GPR84 Q9NQS5 1/20 0.43
DHFR P00374 1/20 0.42
AURKA O14965 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27216702 0.97 GSTP1 (0.46) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL27216699 0.95 MEN1 (0.47) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL24377041 0.95 GSTP1 (0.47) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL27456353 0.95 MEN1 (0.46) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL23633508 0.93 MEN1 (0.49) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL25798751 0.92 MCL1 (0.44) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL24564863 0.92 MEN1 (0.47) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL22414173 0.91 MEN1 (0.50) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL26154400 0.91 MEN1 (0.43) GSTP1MEN1KMT2AKDM4EALDH1A1
SCHEMBL25682938 0.91 MEN1 (0.50) GSTP1MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ETV6 GSTP1 2312/4885MEN1 1080/4885KMT2A 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.